Sotera Health Company Common Stock
SHCNasdaqCIK 1822479Healthcare / Healthcare Providers & Servicesfiscal year ends December27 quarters since 2020
Latest quarter Q3 FY2026, filed November 3, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
Share price
Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.
The last 16 quarters
Q4 FY2022 to Q3 FY2026, through the filing of November 3, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q3 FY2026 filed November 3, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Nov 3, 2026 | Q2 FY2026ended Jun 30, 2026filed Aug 6, 2026 | Q1 FY2026ended Mar 31, 2026filed May 5, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 24, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 4, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025 | Q1 FY2025ended Mar 31, 2025filed May 1, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 27, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 325 | 321 | 280 | 303 | 311 | 294 | 255 | 290 | +4.4% |
| Cost of revenue | 144 | 143 | 133 | 138 | 134 | 128 | 119 | 126 | +7.7% |
| Gross profit | 181 | 178 | 147 | 166 | 178 | 167 | 135 | 164 | +1.8% |
| Research and development | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 64 | 68 | 68 | 58 | 63 | 69 | 63 | 62 | +1.3% |
| Operating income | — | — | — | — | — | — | — | 87 | — |
| Other income (expense) | 3 | 3 | 1 | 2 | 0 | 6 | 0 | 1 | +571.1% |
| Pretax income | 84 | 78 | 43 | 70 | 73 | 19 | (15) | 45 | +14.8% |
| Income tax | 25 | 24 | 16 | 36 | 25 | 11 | (2) | 33 | +3.3% |
| Net income | 58 | 54 | 27 | 35 | 48 | 8 | (13) | 12 | +20.6% |
| Diluted EPS ($) | 0.20 | 0.19 | 0.09 | — | 0.17 | 0.03 | (0.05) | — | +17.6% |
| Diluted shares (millions) | 289 | 288 | 288 | — | 287 | 286 | 284 | — | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q3 FY2026 filed November 3, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Nov 3, 2026 | Q2 FY2026ended Jun 30, 2026filed Aug 6, 2026 | Q1 FY2026ended Mar 31, 2026filed May 5, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 24, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 4, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025 | Q1 FY2025ended Mar 31, 2025filed May 1, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 27, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 412 | 357 | 314 | 345 | 299 | 332 | 304 | 277 | +37.8% |
| Short-term investments | — | — | — | — | — | — | — | — | — |
| Total current assets | 701 | 646 | 586 | 613 | 578 | 608 | 555 | 526 | +21.3% |
| Total assets | 3,387 | 3,307 | 3,236 | 3,263 | 3,186 | 3,217 | 3,098 | 3,072 | +6.3% |
| Total current liabilities | 224 | 231 | 208 | 250 | 242 | 246 | 226 | 191 | −7.7% |
| Long-term debt | 2,123 | 2,126 | 2,124 | 2,127 | 2,129 | 2,203 | 2,205 | 2,208 | −0.3% |
| Total debt | 2,137 | 2,139 | 2,138 | 2,141 | 2,143 | 2,217 | 2,220 | 2,223 | −0.3% |
| Total liabilities | 2,654 | 2,641 | 2,613 | 2,657 | 2,636 | 2,705 | 2,683 | 2,667 | +0.7% |
| Stockholders’ equity | 733 | 666 | 623 | 606 | 550 | 511 | 414 | 405 | +33.2% |
| Shares outstanding (millions) | 286 | 285 | 285 | 284 | 284 | 284 | 284 | 283 | — |
Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q3 FY2026 filed November 3, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Nov 3, 2026 | Q2 FY2026ended Jun 30, 2026filed Aug 6, 2026 | Q1 FY2026ended Mar 31, 2026filed May 5, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 24, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 4, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025 | Q1 FY2025ended Mar 31, 2025filed May 1, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 27, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 111 | 88 | 29 | 103 | 71 | 57 | 56 | 56 | +55.4% |
| Capital expenditures | 53 | 46 | 46 | 51 | 36 | 31 | 20 | 66 | +46.1% |
| Free cash flow (CFO − capex) | 58 | 42 | (17) | 52 | 35 | 26 | 36 | (10) | +65.0% |
| Depreciation and amortization | 33 | 33 | 31 | 33 | 28 | 35 | 41 | 40 | +14.7% |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed February 24, 2026.
Income statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 24, 2026 | FY2024ended Dec 31, 2024filed Feb 27, 2025 | FY2023ended Dec 31, 2023filed Feb 27, 2024 | FY2022ended Dec 31, 2022filed Feb 28, 2023 | FY2021ended Dec 31, 2021filed Mar 1, 2022 | FY2020ended Dec 31, 2020filed May 13, 2021 | FY2019ended Dec 31, 2019filed Mar 1, 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,164 | 1,100 | 1,049 | 1,004 | 931 | 818 | 778 |
| Cost of revenue | 518 | 498 | 472 | 447 | 413 | 375 | 383 |
| Gross profit | 646 | 602 | 577 | 557 | 519 | 444 | 395 |
| Research and development | — | — | — | — | — | — | — |
| Selling, general and administrative | 253 | 243 | 237 | 246 | 198 | 179 | 147 |
| Operating income | — | 298 | 277 | 248 | 257 | 206 | 184 |
| Other income (expense) | 9 | 5 | 7 | 6 | 15 | 9 | 7 |
| Pretax income | 148 | 114 | 106 | (243) | 176 | (39) | (1) |
| Income tax | 70 | 69 | 55 | (10) | 59 | (1) | 20 |
| Net income | 78 | 44 | 51 | (234) | 117 | (39) | (21) |
| Diluted EPS ($) | 0.27 | 0.16 | 0.18 | (0.83) | 0.41 | (0.16) | (0.09) |
| Diluted shares (millions) | 286 | 285 | 283 | 280 | 279 | 238 | 232 |
Balance sheet
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 24, 2026 | FY2024ended Dec 31, 2024filed Feb 27, 2025 | FY2023ended Dec 31, 2023filed Feb 27, 2024 | FY2022ended Dec 31, 2022filed Feb 28, 2023 | FY2021ended Dec 31, 2021filed Mar 1, 2022 | FY2020ended Dec 31, 2020filed May 13, 2021 | FY2019ended Dec 31, 2019filed Mar 1, 2022 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 345 | 277 | 296 | 395 | 107 | 102 | — |
| Short-term investments | — | — | — | — | — | — | — |
| Total current assets | 613 | 526 | 557 | 645 | 346 | 315 | — |
| Total assets | 3,263 | 3,072 | 3,130 | 3,118 | 2,790 | 2,761 | — |
| Total current liabilities | 250 | 191 | 231 | 792 | 161 | 141 | — |
| Long-term debt | 2,127 | 2,208 | 2,224 | 1,747 | 1,744 | 1,825 | — |
| Total debt | 2,141 | 2,223 | 2,228 | 1,944 | 1,744 | 1,825 | — |
| Total liabilities | 2,657 | 2,667 | 2,687 | 2,767 | 2,203 | 2,307 | — |
| Stockholders’ equity | 606 | 405 | 444 | 350 | 586 | 452 | — |
| Shares outstanding (millions) | 284 | 283 | 283 | 282 | 283 | — | — |
Cash flow statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 24, 2026 | FY2024ended Dec 31, 2024filed Feb 27, 2025 | FY2023ended Dec 31, 2023filed Feb 27, 2024 | FY2022ended Dec 31, 2022filed Feb 28, 2023 | FY2021ended Dec 31, 2021filed Mar 1, 2022 | FY2020ended Dec 31, 2020filed May 13, 2021 | FY2019ended Dec 31, 2019filed Mar 1, 2022 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 287 | 224 | (148) | 278 | 282 | 121 | 149 |
| Capital expenditures | 138 | 179 | 215 | 182 | 102 | 54 | 57 |
| Free cash flow (CFO − capex) | 149 | 45 | (363) | 96 | 179 | 67 | 92 |
| Depreciation and amortization | 95 | 84 | 77 | 64 | 64 | 63 | 67 |
| Share repurchases | — | — | — | 0 | 0 | 34 | 0 |
| Dividends paid | — | — | — | — | 0 | 0 | 691 |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Petras Michael B. Jr. | Executive Chairman, Director | open-market sale | 294,515 | $18.50 | $5M | 397,912 | Aug 19, 2026 |
| Aug 17, 2026 | Petras Michael B. Jr. | Executive Chairman, Director | open-market saleindirect | 850,000 | $18.50 | $16M | 4M | Aug 19, 2026 |
| Aug 7, 2026 | Rutz Michael P | President of Sterigenics | open-market sale | 150,000 | $18.84 | $3M | 334,279 | Aug 11, 2026 |
| Aug 5, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | tax withholding | 11,316 | $17.98 | $203K | 217,304 | Aug 7, 2026 |
| May 26, 2026 | Shader Alton | Chief Executive Officer, Director | award | 375,939 | $0.00 | — | 375,939 | May 27, 2026 |
| May 26, 2026 | Shader Alton | Chief Executive Officer, Director | award | 203,634 | $0.00 | — | 579,573 | May 27, 2026 |
| May 22, 2026 | Klee Ann R. | Director | award | 14,970 | $0.00 | — | 140,926 | May 27, 2026 |
| May 22, 2026 | Kyle Richard G | Director | award | 14,970 | $0.00 | — | 14,970 | May 27, 2026 |
| May 22, 2026 | Krause Kenneth D. | Director | award | 14,970 | $0.00 | — | 14,970 | May 27, 2026 |
| May 22, 2026 | Cunningham Sean Laurence | Director | award | 14,970 | $0.00 | — | 95,751 | May 27, 2026 |
| May 22, 2026 | Flynn Karen | Director | award | 14,970 | $0.00 | — | 54,191 | May 27, 2026 |
| May 22, 2026 | Neary James | Director | award | 14,970 | $0.00 | — | 95,751 | May 27, 2026 |
| May 22, 2026 | Petrella Vincent K | Director | award | 14,970 | $0.00 | — | 95,751 | May 27, 2026 |
| May 22, 2026 | Chen Ruoxi | Director | award | 14,970 | $0.00 | — | 95,751 | May 27, 2026 |
| May 22, 2026 | Simon, Christopher | Director | award | 14,970 | $0.00 | — | 34,102 | May 27, 2026 |
| May 22, 2026 | Wheadon David E. | Director | award | 14,970 | $0.00 | — | 89,882 | May 27, 2026 |
| May 13, 2026 | Warburg Pincus & CO.+7 more | Director, 10% owner | open-market saleindirect | 19M | $15.17 | $290M | 0 | May 15, 2026 |
| May 13, 2026 | Warburg Pincus & CO.+9 more | Director, 10% owner | open-market saleindirect | 19M | $15.17 | $290M | 0 | May 15, 2026 |
| May 13, 2026 | Gtcr Investment XI LLC+4 more | Director, 10% owner | open-market saleindirect | 13M | $15.17 | $193M | 0 | May 15, 2026 |
| Mar 31, 2026 | Dimitrief Alexander | Former SVP, GC and Sec. | tax withholding | 7,941 | $14.34 | $114K | 312,040 | Apr 2, 2026 |
| Mar 6, 2026 | Warburg Pincus Partners GP LLC+7 more | Director, 10% owner | open-market saleindirect | 15M | $15.27 | not summed | 19M | Mar 10, 2026 |
| Mar 6, 2026 | Warburg Pincus Partners II, L.P.+9 more | Director, 10% owner | open-market saleindirect | 15M | $15.27 | $229M | 19M | Mar 10, 2026 |
| Mar 6, 2026 | Gtcr Co-Invest XI LP+4 more | Director, 10% owner | open-market saleindirect | 10M | $15.27 | $153M | 13M | Mar 10, 2026 |
| Mar 2, 2026 | Petras Michael B. Jr. | Chairman & CEO, Director | tax withholding | 31,339 | $15.91 | $499K | 521,451 | Mar 4, 2026 |
| Mar 2, 2026 | Petras Michael B. Jr. | Chairman & CEO, Director | tax withholding | 40,302 | $15.91 | $641K | 481,149 | Mar 4, 2026 |
Full insider history for Sotera Health Company Common Stock, or insider activity across all companies. A record of filings, not a recommendation.
Tracked funds holding it
1 of the tracked managers held SHC in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded SHC by quarter.
| Fund | Manager | Quarter | Value | Shares | Weight | Move |
|---|---|---|---|---|---|---|
| Greenlight Capital | David Einhorn | Q2 2026 | $73M | 4M | 1.88% | added +100.2% |
Sources
Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- SOTERA HEALTH COMPANY, CIK 1822479 on EDGAR
- Extract generated
- November 16, 2026
- Withheld
- none
- Repaired
- none
XBRL concepts behind each line
Income statement
RevenueFromContractWithCustomerExcludingAssessedTaxCostOfRevenueGrossProfitSellingGeneralAndAdministrativeExpenseOperatingIncomeLossOtherNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueAssetsCurrentAssetsLiabilitiesCurrentLongTermDebt, LongTermDebtNoncurrentLongTermDebtLiabilitiesStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquirePropertyPlantAndEquipmentDepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockPaymentsOfDividendsThe data
The statements on this page as files, generated November 16, 2026.
- JSON file
/data/financials/SHC.json